MOMENTA PHARMACEUTICALS INC 4
4 · MOMENTA PHARMACEUTICALS INC · Filed Apr 19, 2016
Insider Transaction Report
Form 4
Bishop John E
Senior VP, Pharmaceutical Scie
Transactions
- Tax Payment
Common Stock
2016-04-18$9.69/sh−6,206$60,136→ 160,880 total - Sale
Common Stock
2016-04-19$9.57/sh−2,843$27,208→ 158,037 total
Footnotes (3)
- [F1]Represents the number of shares of restricted common stock returned to the company to meet minimum tax liability requirements, pursuant to the related exercise and restricted stock agreement, as amended, between Mr. Bishop and the Company. The shares were awarded pursuant to the Company's 2004 Stock Incentive Plan, as amended.
- [F2]This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 9, 2015.
- [F3]This transaction was executed in multiple trades at prices ranging from $9.45 to $9.73. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.